Keros Therapeutics Inc (KROS)
57.77
-0.47
(-0.81%)
USD |
NASDAQ |
May 09, 16:00
57.50
-0.27
(-0.47%)
After-Hours: 20:00
Keros Therapeutics Shareholders Equity (Quarterly): 453.95M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 453.95M |
| December 31, 2023 | 332.21M |
| September 30, 2023 | 295.84M |
| June 30, 2023 | 326.26M |
| March 31, 2023 | 354.98M |
| December 31, 2022 | 277.42M |
| September 30, 2022 | 241.02M |
| June 30, 2022 | 211.21M |
| March 31, 2022 | 223.49M |
| Date | Value |
|---|---|
| December 31, 2021 | 243.17M |
| September 30, 2021 | 218.48M |
| June 30, 2021 | 235.66M |
| March 31, 2021 | 248.37M |
| December 31, 2020 | 261.72M |
| September 30, 2020 | 130.76M |
| June 30, 2020 | 141.36M |
| March 31, 2020 | 50.86M |
| December 31, 2019 | 0.495M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.495M
Minimum
Dec 2019
453.95M
Maximum
Mar 2024
235.96M
Average
242.10M
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 26.99B |
| Scholar Rock Holding Corp | 182.77M |
| Morphic Holding Inc | 663.58M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 485.82M |
| Total Liabilities (Quarterly) | 31.87M |
| Current Ratio | 24.74 |